These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 24850580)

  • 1. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
    Benedict RH; Smerbeck A; Parikh R; Rodgers J; Cadavid D; Erlanger D
    Mult Scler; 2012 Sep; 18(9):1320-5. PubMed ID: 22277740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
    Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Burggraaff J; Knol DL; Uitdehaag BMJ
    Eur Neurol; 2017; 77(5-6):246-252. PubMed ID: 28319952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
    Strober L; Chiaravalloti N; Moore N; DeLuca J
    Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental learning during rapid information processing on the symbol-digit modalities test.
    Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
    Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
    Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
    J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.